Intra‑arterial PRRT with Lu‑177 DOTATATE in Liver‑dominant Metastatic Neuroendocrine Tumors: Early Assessment of Efficacy and Toxicity.

MLA

Puranik, Ameya D., et al. “Intra‑arterial PRRT with Lu‑177 DOTATATE in Liver‑dominant Metastatic Neuroendocrine Tumors: Early Assessment of Efficacy and Toxicity.” Indian Journal of Nuclear Medicine, vol. 39, no. 2, Mar. 2024, pp. 71–76. EBSCOhost, https://doi.org/10.4103/ijnm.ijnm_7_23.

APA

Puranik, A. D., Rangarajan, V., Shetty, N. S., Gala, K., Kulkarni, S., Mohite, A., Marotkar, M., Gawale, Y., Dev, I. D., Shrikhande, S. V., Chaudhari, V., Bhandare, M., Agrawal, A., Shah, S., Purandare, N. C., Ghosh, S., & Choudhury, S. (2024). Intra‑arterial PRRT with Lu‑177 DOTATATE in Liver‑dominant Metastatic Neuroendocrine Tumors: Early Assessment of Efficacy and Toxicity. Indian Journal of Nuclear Medicine, 39(2), 71–76. https://doi.org/10.4103/ijnm.ijnm_7_23

Chicago

Puranik, Ameya D., Venkatesh Rangarajan, Nitin Sudhakar Shetty, Kunal Gala, Suyash Kulkarni, Ashish Mohite, Mandar Marotkar, et al. 2024. “Intra‑arterial PRRT with Lu‑177 DOTATATE in Liver‑dominant Metastatic Neuroendocrine Tumors: Early Assessment of Efficacy and Toxicity.” Indian Journal of Nuclear Medicine 39 (2): 71–76. doi:10.4103/ijnm.ijnm_7_23.